Literature DB >> 8842276

Cryptococcus neoformans infection in France: epidemiologic features of and early prognostic parameters for 76 patients who were infected with human immunodeficiency virus.

C Darras-Joly1, S Chevret, M Wolff, S Matheron, P Longuet, E Casalino, V Joly, C Chochillon, J P Bédos.   

Abstract

We retrospectively carried out a descriptive and prognostic study of 76 human immunodeficiency virus-infected patients with cryptococcosis diagnosed by a positive culture of cerebrospinal fluid (CSF), blood, urine, or other body fluid or tissue. We focused on the 65 patients with cryptococcal meningitis. At diagnosis, the mean CD4 lymphocyte count was 46/mm3; 86% of patients had fever; 67%, headache; 37%, stiff neck; 29%, altered mentation or confusion; 20% cranial nerve deficiency; and 48%, other focal deficiencies. Analysis of CSF specimens revealed the following results: normal (25% of the specimens), leukocyte count of < 20/mm3 (62%), positive India ink smear (87%), and positive cryptococcal antigen (92%). Twenty patients died within the first 3 months (3-month survival rate, 70%). A Cox regression model selected the following as prognostic parameters: age older than 30 years (relative risk [RR] = 2.1), CSF glucose level of < 2 mmol/L (RR = 3.7), previous admission to an intensive care unit (RR = 4.7), and mechanical ventilation (RR = 4.6). The outcome of cryptococcal meningitis in patients with AIDS remains difficult to predict at admission, and every case should be considered as potentially severe.

Entities:  

Mesh:

Year:  1996        PMID: 8842276     DOI: 10.1093/clinids/23.2.369

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  14 in total

1.  Prediction of unfavorable outcomes in cryptococcal meningitis: results of the multicenter Infectious Diseases International Research Initiative (ID-IRI) cryptococcal meningitis study.

Authors:  I N Hakyemez; H Erdem; G Beraud; M Lurdes; A Silva-Pinto; C Alexandru; B Bishop; F Mangani; X Argemi; M Poinot; R Hasbun; M Sunbul; M Akcaer; S Alp; T Demirdal; K Angamuthu; F Amer; E Ragab; G A Shehata; D Ozturk-Engin; N Ozgunes; L Larsen; S Zimmerli; O R Sipahi; E Tukenmez Tigen; G Celebi; N Oztoprak; A C Yardimci; Y Cag
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-12-08       Impact factor: 3.267

2.  Cryptococcal meningitis in Senegal: epidemiology, laboratory findings, therapeutic and outcome of cases diagnosed from 2004 to 2011.

Authors:  Doudou Sow; Roger Clément Tine; Khadime Sylla; Mansata Djiba; Cheikh Tidiane Ndour; Thérèse Dieng; Jean Louis Ndiaye; Babacar Faye; Daouda Ndiaye; Oumar Gaye; Yémou Dieng
Journal:  Mycopathologia       Date:  2013-10-25       Impact factor: 2.574

3.  Approaches to antifungal therapies and their effectiveness among patients with cryptococcosis.

Authors:  Emily W Bratton; Nada El Husseini; Cody A Chastain; Michael S Lee; Charles Poole; Til Stürmer; David J Weber; Jonathan J Juliano; John R Perfect
Journal:  Antimicrob Agents Chemother       Date:  2013-03-11       Impact factor: 5.191

Review 4.  Opportunistic Neurologic Infections in Patients with Acquired Immunodeficiency Syndrome (AIDS).

Authors:  Fritzie Albarillo; Paul O'Keefe
Journal:  Curr Neurol Neurosci Rep       Date:  2016-01       Impact factor: 5.081

Review 5.  New Insights into HIV/AIDS-Associated Cryptococcosis.

Authors:  Spinello Antinori
Journal:  ISRN AIDS       Date:  2013-02-25

6.  Concurrent central nervous system infective pathology in a severely immunocompromised patient.

Authors:  Thein Swe; Bordes P Laurent; Nickul N Shah
Journal:  J Family Med Prim Care       Date:  2016 Jul-Sep

7.  Neurosyphilis with Concomitant Cryptococcal and Tuberculous Meningitis in a Patient with AIDS: Report of a Unique Case.

Authors:  Jose Armando Gonzales Zamora; Luis Alberto Espinoza; Rita N Nwanyanwu
Journal:  Case Rep Infect Dis       Date:  2017-08-27

8.  Incidence, clinical presentation, and outcome of HIV-1-associated cryptococcal meningitis during the highly active antiretroviral therapy era: a nationwide cohort study.

Authors:  Madeleine Touma; Line D Rasmussen; Raquel Martin-Iguacel; Frederik Neess Engsig; Nina Breinholt Stærke; Mette Stærkind; Niels Obel; Magnus Glindvad Ahlström
Journal:  Clin Epidemiol       Date:  2017-07-21       Impact factor: 4.790

9.  Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era.

Authors:  Caroline Charlier; Françoise Dromer; Christophe Lévêque; Loïc Chartier; Yves-Sébastien Cordoliani; Arnaud Fontanet; Odile Launay; Olivier Lortholary
Journal:  PLoS One       Date:  2008-04-16       Impact factor: 3.240

10.  Old Cryptococcus neoformans cells contribute to virulence in chronic cryptococcosis.

Authors:  Tejas Bouklas; Ximo Pechuan; David L Goldman; Batya Edelman; Aviv Bergman; Bettina C Fries
Journal:  mBio       Date:  2013-08-13       Impact factor: 7.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.